Evolution of interferon-beta binding antibodies in MS patients may predict development of neutralizing antibodies

被引：12
|
作者：
Mayr, M
Berek, K
Deisenhammer, F
机构：
[1] Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria
[2] Dist Hosp Kufstein, Dept Neurol, Kufstein, Austria
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2003年 / 10卷 / 04期
关键词：
antibodies; binding; interferon beta; multiple sclerosis; neutralizing;
D O I：
10.1046/j.1468-1331.2003.00608_2.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：462 / 464
页数：3
相关论文
共 50 条
  • [41] Clinical Outcomes in Patients with Multiple Sclerosis who Develop Neutralizing Antibodies to Recombinant Interferon-Beta Treatment
    Fink, Katharina
    Westerlind, Helga
    Lundkvist, Malin
    Fogdell-Hahn, Anna
    Hillert, Jan
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73 (04) : 369 - 370
  • [42] Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patients
    Bertolotto, A
    Gilli, F
    Sala, A
    Capobianco, M
    Malucchi, S
    Milano, E
    Melis, F
    Marnetto, F
    Lindberg, RLP
    Bottero, R
    Di Sapio, A
    Giordana, MT
    NEUROLOGY, 2003, 60 (04) : 634 - 639
  • [43] Interferon-beta neutralising antibodies in Canadian multiple sclerosis patients treated with different interferon-beta products
    Grossberg, S. E.
    Gehshan, A.
    Long, C.
    Chuppa, S. L.
    Nicholson, K.
    Grossberg, L. D.
    MULTIPLE SCLEROSIS, 2006, 12 : S207 - S208
  • [44] Neutralizing Antibodies to Interferon in Children with MS on Interferon Treatment
    Yeh, E.
    Heim, R.
    Karpinski, M.
    Ray, J.
    Weinstock-Guttman, B.
    ANNALS OF NEUROLOGY, 2009, 66 : S119 - S119
  • [45] Daclizumab exhibits efficacy in multiple sclerosis subjects positive for interferon-beta neutralizing antibodies
    Neyer, Lauri
    Singer, Robert
    Wang, Helen
    Caras, Ingrid
    MULTIPLE SCLEROSIS, 2008, 14 : S169 - S169
  • [46] Correlation between anti-interferon-beta binding and neutralising antibodies in multiple sclerosis patients on interferon-beta therapy
    Jensen, P. E. H.
    Sellebjerg, F.
    Sondergaard, H. B.
    Sorensen, P. S.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S120 - S120
  • [47] DO BINDING ANTIBODIES PREDICT NEUTRALIZING ANTIBODY DEVELOPMENT IN MULTIPLE SCLEROSIS PATIENTS?
    Ivanova, Sonya
    Skrobanska, Raliza
    Kolyovska, Vera
    Milanov, Ivan
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2018, 71 (08): : 1139 - 1146
  • [48] Genetic factors influencing the development of binding and neutralizing antibodies against interferon beta treatment in multiple sclerosis patients
    Andlauer, T. F. M.
    Link, J.
    Buck, D.
    Ryner, M.
    Grummel, V.
    Auer, M.
    Hegen, H.
    Gasperi, C.
    Mueller-Myhsok, B.
    Jensen, P. E. Hyldgaard
    Sellebjerg, F. T.
    Kockum, I.
    Olsson, T.
    Pallardy, M.
    Spindeldreher, S.
    Deisenhammer, F.
    Fogdell-Hahn, A.
    Hemmer, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 507 - 508
  • [49] Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosis
    Florian Deisenhammer
    Huub Schellekens
    Antonio Bertolotto
    Journal of Neurology, 2004, 251 : ii31 - ii39
  • [50] Commentary on neutralizing antibodies to interferon beta in patients with multiple sclerosis
    Whitaker, JN
    ARCHIVES OF NEUROLOGY, 2001, 58 (08) : 1301 - 1301
12345